ConductScience.org, home

Paper18200041

Genetics of therapy-related myelodysplasia and acute myeloid leukemia.

Pedersen-Bjergaard J and 3 others. Leukemia, 2008. Cited by 173 papers, by iCite.

Cite this record

ConductScience Library. Genetics of therapy-related myelodysplasia and acute myeloid leukemia. Papers, record 18200041. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18200041

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Genetics of therapy-related myelodysplasia and acute myeloid leukemia.
PubMed
Journal
Leukemia
PubMed
Year
2008
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
173
iCite
Relative citation ratio, by iCite
3.71
iCite
Revised in PubMed
2026-10-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pedersen-Bjergaard JJ
2Andersen MKM K
3Andersen MTM T
4Christiansen DHD H

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Leukemia, Myeloid, AcuteMajor topic
MutationMajor topic
Myelodysplastic SyndromesMajor topic
Neoplasms, Second PrimaryMajor topic
Humans
Signal Transduction
Transcription Factors

Source PubMed

Download CSV of topics

References64

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112970781Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia.Leukemia2003https://conductscience.org/library/papers/12970781PubMed
216281072Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia.Leukemia2005https://conductscience.org/library/papers/16281072PubMed
312454741
Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001.
Leukemia2002https://conductscience.org/library/papers/12454741PubMed
412194988Genetics of myeloid leukemias.Annu Rev Genomics Hum Genet2002https://conductscience.org/library/papers/12194988PubMed
53950675
Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.
J Clin Oncol1986https://conductscience.org/library/papers/3950675PubMed
616051734Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations.Blood2005https://conductscience.org/library/papers/16051734PubMed
716434492Implications of NRAS mutations in AML: a study of 2502 patients.Blood2006https://conductscience.org/library/papers/16434492PubMed
814615365High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia.Blood2004https://conductscience.org/library/papers/14615365PubMed
99746770The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.Blood1998https://conductscience.org/library/papers/9746770PubMed
1017159988Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.Nat Med2007https://conductscience.org/library/papers/17159988PubMed
117579462Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia.Blood1995https://conductscience.org/library/papers/7579462PubMed
1217910630RUNX1 gene mutation in primary myelodysplastic syndrome--the mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome.Br J Haematol2007https://conductscience.org/library/papers/17910630PubMed
1315951308RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years.Blood2005https://conductscience.org/library/papers/15951308PubMed
148943866Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype.Blood1996https://conductscience.org/library/papers/8943866PubMed
1514726504CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations.J Clin Oncol2004https://conductscience.org/library/papers/14726504PubMed
1616980411Granulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptor.Proc Natl Acad Sci U S A2006https://conductscience.org/library/papers/16980411PubMed
1716893685Chromatin structural elements and chromosomal translocations in leukemia.DNA Repair (Amst)2006https://conductscience.org/library/papers/16893685PubMed
1816990778Alternative genetic pathways and cooperating genetic abnormalities in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia.Leukemia2006https://conductscience.org/library/papers/16990778PubMed
1916467864Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations.Leukemia2006https://conductscience.org/library/papers/16467864PubMed
209665199Establishment and characterization of a megakaryoblast cell line with amplification of MLL.Leukemia1998https://conductscience.org/library/papers/9665199PubMed

See all 64 referencesDownload CSV of references

Cited by98

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 173 citations.

PMIDTitleJournalYearIn PapersSource
42278263TP53 Mutations Unfavorably Impact the Outcomes of Myelofibrosis Patients with or Without Hematopoietic Stem Cell Transplantation: A Single-Center Study and Meta-Analysis.Int J Mol Sci2026https://conductscience.org/library/papers/42278263PubMed
40227798Low WT1 Expression Identifies a Subset of Acute Myeloid Leukemia with a Distinct Genotype.Cancers (Basel)2025https://conductscience.org/library/papers/40227798PubMed
40138078Risk of secondary myeloid neoplasms following treatment in patients with grade I-II follicular lymphoma: a retrospective cohort study.Discov Oncol2025https://conductscience.org/library/papers/40138078PubMed
40133836Transcriptomic characterisation of acute myeloid leukemia cell lines bearing the same t(9;11) driver mutation reveals different molecular signatures.BMC Genomics2025https://conductscience.org/library/papers/40133836PubMed
39940930Emergence and Cytogenetic Clonal Evolution of Chromosome 7 Abnormalities in Myeloid Malignancies: Investigating the Role of Telomere Dysfunction.Int J Mol Sci2025https://conductscience.org/library/papers/39940930PubMed
39422544Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant Microenvironment.Blood Cancer Discov2024https://conductscience.org/library/papers/39422544PubMed
38541635Recent Advances towards the Understanding of Secondary Acute Myeloid Leukemia Progression.Life (Basel)2024https://conductscience.org/library/papers/38541635PubMed
38178263Vemurafenib induces senescence in acute myeloid leukemia and myelodysplastic syndrome by activating the HIPPO signaling pathway: implications for potential targeted therapy.Biol Direct2024https://conductscience.org/library/papers/38178263PubMed
37917833Criteria for Diagnosis and Molecular Monitoring of NPM1-Mutated AML.Blood Cancer Discov2024https://conductscience.org/library/papers/37917833PubMed
37847561A gain-of-function p53 mutant synergizes with oncogenic NRAS to promote acute myeloid leukemia in mice.J Clin Invest2023https://conductscience.org/library/papers/37847561PubMed
37088806Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics.Blood Cancer J2023https://conductscience.org/library/papers/37088806PubMed
36980546Progress toward Better Treatment of Therapy-Related AML.Cancers (Basel)2023https://conductscience.org/library/papers/36980546PubMed
36696829Therapy-selected clonal hematopoiesis and its role in myeloid neoplasms.Leuk Res2023https://conductscience.org/library/papers/36696829PubMed
36077220Recurrent Translocations in Topoisomerase Inhibitor-Related Leukemia Are Determined by the Features of DNA Breaks Rather Than by the Proximity of the Translocating Genes.Int J Mol Sci2022https://conductscience.org/library/papers/36077220PubMed
36040481Functional association of NR4A3 downregulation with impaired differentiation in myeloid leukemogenesis.Ann Hematol2022https://conductscience.org/library/papers/36040481PubMed
35740508CPX-351: An Old Scheme with a New Formulation in the Treatment of High-Risk AML.Cancers (Basel)2022https://conductscience.org/library/papers/35740508PubMed
35615324De Novo and Therapy-Related Myelodysplastic Syndromes: Analogies and Differences.Mediterr J Hematol Infect Dis2022https://conductscience.org/library/papers/35615324PubMed
35280084Myelodysplastic syndrome in a case of new-onset pancytopenia.Clin Case Rep2022https://conductscience.org/library/papers/35280084PubMed
34639121TP53 in Acute Myeloid Leukemia: Molecular Aspects and Patterns of Mutation.Int J Mol Sci2021https://conductscience.org/library/papers/34639121PubMed
34428556Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults.Transplant Cell Ther2021https://conductscience.org/library/papers/34428556PubMed

See all 98 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
RUNX1861PubTator's text mininghttps://conductscience.org/library/genes/861NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene
TXK7294PubTator's text mininghttps://conductscience.org/library/genes/7294NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/18200041

GET https://conductscience.org/api/papers/v1/18200041/references?page=2